Latest Headlines

  1. Avance Clinical Launches Diversity In STEM Scholarships Across Australia And North America 12/22/2025

    Avance Clinical, the award-winning global CRO for biotechs, has announced the launch of its new Diversity in STEM Scholarships, a global initiative designed to support women and minority-group students pursuing careers in science, technology, engineering, and mathematics (STEM). The program includes dedicated intakes in Australia and the broader Asia-Pacific region, as well as North America, reinforcing the company’s commitment to equity and inclusion in clinical research.

  2. Minaris And Cell And Gene Therapy Catapult Announce Collaboration To Advance Delivery Methods For Cell And Gene Therapies 12/18/2025

    Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider and Cell and Gene Therapy Catapult (CGT Catapult), an independent technology and innovation organization specializing in the advancement of the CGT industry, today announced a collaboration to develop CGT delivery technologies to enable more robust manufacturing processes, improved quality, and lower cost of goods.

  3. Andelyn Biosciences Announces Partnership With Jaguar Gene Therapy To Provide Late-Stage PPQ Manufacturing 12/8/2025

    Andelyn Biosciences, a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Jaguar Gene Therapy to perform late-stage Process Performance Qualification (PPQ) manufacturing of JAG201, an investigational gene therapy targeting SHANK3 haploinsufficiency which is clinically diagnosed as Phelan-McDermid syndrome (PMS), a leading monogenic cause of autism spectrum disorder (ASD).

  4. Solid Biosciences Announces Licensing Agreement With Andelyn Biosciences For The Use Of Proprietary Next-Generation Capsid AAV-SLB101 11/17/2025

    Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced a non-exclusive worldwide license and collaboration agreement with Andelyn Biosciences (Andelyn), a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), for the use of Solid’s proprietary, next-generation capsid, AAV-SLB101.

  5. AES Cleanroom Technology Establishes New Office In Research Triangle Park To Support Regional Drug Manufacturing Growth 11/11/2025

    AES Cleanroom Technology, an award-winning leader in modular cleanroom design and construction, has opened a new regional office in Research Triangle Park (RTP), reinforcing its commitment to serving the Southeast’s fast-growing life sciences, biotechnology, and advanced manufacturing sectors.

  6. Vector BioMed Expands LENTIVERSE™, Rebrands to Advance CGT 11/6/2025

    Vector BioMed expands LENTIVERSE™ with two solutions, VectorCraft and LaunchSuite, to accelerate global gene therapy access through transparent economics, streamlined manufacturing, and a bold new brand.

  7. Avance Clinical Showcases Early Phase Expertise And The Australian Advantage For EU Biotechs At BIO-Europe Vienna 11/5/2025

    Avance Clinical, the largest premium full-service Australian headquartered CRO with more than 30 years of early phase expertise, is highlighting its Early Phase Center of Excellence for Biotechs and the well-established Australian Advantage to European biotechs ahead of BIO-Europe in Vienna, November 3-5, 2025.

  8. Meet Avance Clinical At SCOPE Summit 2026 In Orlando, Florida 11/5/2025

    Avance Clinical is excited to announce our participation in SCOPE Summit 2026, one of the most influential gatherings in clinical operations, where leading innovators in biotech, pharma, CROs, and technology come together to share strategies shaping the future of global drug development.

  9. Avance Clinical Launches Renal And Cardiometabolic Center Of Excellence To Optimize Patient Recruitment To Elevate Study Success 10/30/2025

    Avance Clinical, a partner for biotechs providing global contract research organization services, has announced the launch of the Renal & Cardiometabolic Center of Excellence.

  10. Tema Sinergie Acquires Majority Stake In Aseptic Filling OEM 6Bio 10/29/2025

    TEMA Sinergie S.p.A., a global leader in isolation systems for the Radiopharma and Biotech Pharma industries, today announced the acquisition of a majority stake in 6Bio, a Spanish company specialized in high-performance aseptic filling technology.